chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Headache, Malaise, Nausea
Clinical narrative: Felt very ill starting 6 days after the injection.; Bad head pain and nausea which was constant; Bad head pain and nausea which was constant; "I" didnt have an appetite but was able to eat some food.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 18Feb2021 at 14:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included morphine sulfate (MANUFACTURER UNKNOWN), hydrocodone (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC), all taken from unknown dates for unspecified indications. On 24Feb2021, at 16:00, 6 days after the injection the patient felt very ill, bad head pain and nausea, which was constant and also had an overall sick feeling. The patient did not have an appetite but was able to eat some food. The patient reported that laying down was the only thing that made him feel slightly better. The closest thing he could compare it to would be a bad hangover that lasted 6 days without feeling better at all. On the seventh day, the patient started feeling a little better. The patient was continuing to improve but was still not completely better on the eighth day (day of report). The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt very ill, bad head pain, nausea, overall sick feeling and did not have an appetite was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Cognitive disorder, Depression, Fatigue
Clinical narrative: Aches; Fatigue; Feeling sick; chills; increased depression; unable to get out of bed/off balance; unclear thinking; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 15Feb2021 at 13:30 (at age of 75-year-old), as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and minor chronic kidney disease. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included trazodone (MANUFACTURER UNKNOWN), citalopram hydrobromide (CELEXA), quetiapine fumarate (SEROQUEL), carbamazepine (TEGRETOL), clonazepam (KLONOPIN) and lisinopril (MANUFACTURER UNKNOWN); all for unspecified indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Feb2021 at 09:00, the patient experienced aches, fatigue, feeling sick, chills, increased depression, unable to get out of bed/ off balance and unclear thinking. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events aches, fatigue, feeling sick, chills, increased depression, unable to get out of bed/ off balance and unclear thinking was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain
Clinical narrative: Aches; Fatigue; Feeling sick; chills; increased depression; unable to get out of bed/off balance; unclear thinking; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 15Feb2021 at 13:30 (at age of 75-year-old), as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and minor chronic kidney disease. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included trazodone (MANUFACTURER UNKNOWN), citalopram hydrobromide (CELEXA), quetiapine fumarate (SEROQUEL), carbamazepine (TEGRETOL), clonazepam (KLONOPIN) and lisinopril (MANUFACTURER UNKNOWN); all for unspecified indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Feb2021 at 09:00, the patient experienced aches, fatigue, feeling sick, chills, increased depression, unable to get out of bed/ off balance and unclear thinking. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events aches, fatigue, feeling sick, chills, increased depression, unable to get out of bed/ off balance and unclear thinking was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Starting day of vaccination  I have been having pain in deltoid muscle causing pain when I use my arm; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm right on 27Feb2021 at 13:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included central respiratory depression, migraine, chronic pain, arm dry, reflux, non allergic rhinitis, cholesterol, back surgery^5, knee total replacement, and Rx L Tibia ORIF. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ATENOLOL; PROTONIC, AREDS2 and VITAMIN D3, all from an unknown date for an unknown indication and unknown if ongoing. The patient previously took EFFEXOR, STATINS. ACE INHIBITORS, and AMBIEN, and experienced drug allergy. On 27Feb2021 at 17:00, the patient experienced had been having pain in deltoid muscle causing pain when using arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of pain in muscle and included treatment with pain medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in muscle was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo positional
Clinical narrative: Positional Vertigo beginning on Day 1 ov Vaccination and persisting at least 30 days after vaccine; This is a spontaneous report from a contactable physician. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 11Feb2021 at 10:00(at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified concomitant medications  On 11Feb2021, the patient experienced positional vertigo beginning on day 1 of vaccination and persisting at least 30 days after vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event positional vertigo beginning on day 1 of vaccination and persisting at least 30 days after vaccine was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Lymphadenopathy, Pain in extremity
Clinical narrative: Swollen lymph nodes, under arm, neck, pelvic area.; Left arm pain is so bad "I" am unable to sleep; Left arm pain is so bad "I" am unable to sleep.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included zolpidem tartrate (AMBIEN), buspirone (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT) and pantoprazole sodium sesquihydrate (PROTONIX); all for unknown indications from unknown dates and unknown if ongoing. On 08Mar2021 at 00:00, the patient experienced swollen lymph nodes, under arm, neck, pelvic area and left arm pain was so bad that the patient was unable to sleep. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes, under arm, neck, pelvic area and left arm pain was so bad that the patient was unable to sleep was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain, Pain in extremity
Clinical narrative: Body aches with no pain in fingers; Pain in back; Pain in legs; Pain toes; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 09:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and allergy to antihistamines. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included lamotrigine (LAMICTAL), levetiracetam (KEPPRA), sertraline hydrochloride (ZOLOFT), lorazepam (ATIVAN) all for an unknown indication from an unknown date and unknown if ongoing.  On 07Mar2021 at 17:00, the patient experienced body aches with no pain in fingers and the main pain was back, legs and toes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, pain in back, legs and toes was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Blood test, Therapeutic response unexpected
Clinical narrative: Positive event/ the day after the vaccine, I woke up with none of my usual issues/ my nose wasn't stuffy, I didn't feel like my body hurt or was achy, I could breath with no issue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 07Mar2021 at 11:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, shingles, pneumonia as a kid multiple times, migraines, allergies/allergic to everything environmental, food sensitivity/have a bunch of food sensitivities and anxiety believed to be caused partly by histamine intolerances. Allergies to medications, food, or other products were reported as "too many to list". The patient had been through allergies shots, allergy tests, blood tests on unknown dates and the patient reacted to everything. The patient woke up every morning and felt like could not breathe and just felt miserable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), zinc sulfate/lecithin/chromium picolinate (LIVER PROTECT), vitamin b complex (MANUFACTURER UNKNOWN), and ascorbic acid (VITAMIN C); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received unspecified allergies shots for unknown indications from unknown dates. The patient reported that this was a positive event. On 08Mar2021 at 06:00, the day after the vaccine, the patient woke up with none of the usual issues that the patient had. This continued through the day. On 09Mar2021, when the patient woke up and it was the same thing. The patient's nose was not stuffy, she did not feel like the body was hurt or was achy and could breathe with no issue. The patient joked that the vaccine had reset the patient's unpredictable immune system which seemed to react to everything. The patient did not know how or why but after the vaccine the patient felt the best she had felt in years - after multiple tests, medications, diet modifications that did not help, it was the weirdest thing and made such an impact which the patient wanted to share it. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event positive event/ the day after the vaccine, the patient woke up with none of the usual issues/ nose was not stuffy, did not feel like body hurt or was achy, the patient could breath with no issue was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased activity, Pain in extremity
Clinical narrative: The second shot caused severe arm pain in entire arm starting about 3hr after shot.; Pain increased until unable to use/lift. Started to decrease some after 72hr; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264, expiration date: an unknown date in May2021) via an unspecified route of administration in the left arm on 03Feb2021 at 13:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure controlled with medication. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included hydrochlorothiazide (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN) and esomeprazole (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246, expiration date: an unknown date in Apr2021) via an unspecified route of administration in the left arm on 12Jan2021 at 13:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The second shot caused severe arm pain in entire arm starting about 3 hours after shot on 03Feb2021 at 16:00. Pain increased until unable to use or lift. Started to decrease some after 72 hours. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event second shot caused severe arm pain in entire arm starting about 3 hours after shot; pain increased until unable to use or lift; started to decrease some after 72 hours was resolved with sequelae on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness, Myalgia, Pain in extremity, Vision blurred
Clinical narrative: Sore arm; Blurry vision; Sore-stiff muscles; Headache; Sore-stiff muscles; This is a spontaneous report from a contactable consumer, the patient. An 87-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:00 (at the age of 87-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, impaired kidney function, osteoarthritis, reflux, scoliosis and COVID-19. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included irbesartan (MANUFACTURER UNKNOWN), metoprolol (METOPROLOL), levothyroxine sodium (SYNTHROID) and amlodipine (AMLODIPINE); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 15:00 (at the age of 87-years-old) as a single dose for COVID-19 immunisation. On 09Mar2021 at 04:00, the patient experienced sore arm, blurry vision, sore-stiff muscles, headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, blurry vision, sore-stiff muscles, headache were not resolved at this time of report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: After 16 hours, onset of nausea; Chill; Muscle aches; Tired; Very swollen lymph node under left arm; Day 1 - headache for first 16 hours; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took fluconazole (DIFLUCAN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and daily iron supplement (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 14Feb2021 at 11:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 07Mar2021, the patient experienced headache for first 16 hours and sore arm. On 08Mar2021 at 02:00,after 16 hours, the patient experienced nausea, chill, muscle aches, tired and very swollen lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 08Mar2021; while that of event sore arm, nausea, chill, muscle aches, tired and very swollen lymph node under left arm were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: After 16 hours, onset of nausea; Chill; Muscle aches; Tired; Very swollen lymph node under left arm; Day 1 - headache for first 16 hours; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took fluconazole (DIFLUCAN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and daily iron supplement (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 14Feb2021 at 11:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 07Mar2021, the patient experienced headache for first 16 hours and sore arm. On 08Mar2021 at 02:00,after 16 hours, the patient experienced nausea, chill, muscle aches, tired and very swollen lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 08Mar2021; while that of event sore arm, nausea, chill, muscle aches, tired and very swollen lymph node under left arm were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large inflamed lymph node in front of neck starting 8 days after vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 09:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included dermatomyositis, migraine and allergy to sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included naltrexone (MANUFACTURER UNKNOWN), estradiol (MINIVELLE) and sumatriptan (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. On 06Mar2021 at 10:00, the patient experienced large inflamed lymph node in front of neck starting 8 days after vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event large inflamed lymph node in front of neck was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Somnolence
Clinical narrative: Groggy; Mild dizziness; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 08Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, sinusitis, rhinitis, latex allergy and allergy to bee stings, tree nuts, peanuts, nightshades, apricots. The patient  was allergic to codeine (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Asthma Meds (unspecified), Zyrtec (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. On 08Mar2021 at 12:30, the patient experienced groggy, exhaustion and mild dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events groggy, exhaustion and mild dizziness was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headache for the past day started around 2 hours after vaccination; Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included Retinoblastoma 1 (RB1) mutation diagnosed at birth, Retinoblastoma (RB) history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pseudoephedrine hydrochloride (MANUFACTURER UNKNOWN) 120mg taken for an unknown indication from an unknown date and unknown if ongoing.  On 08Mar2021 at 18:30, around 2 hours after vaccination, the patient experienced headache for the same day and sore left arm; nothing major besides headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and sore left arm were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Anxiety, Fatigue, Head discomfort, Nausea
Clinical narrative: Head pressure; Light sensitivity; Extreme anxiety; Fatigue; Nausea; Vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 17:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), dysautonomia, lyme disease, antiphospholipid syndrome and  sulfonamide allergy (sulfa abx). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 20:00, the patient experienced head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams were not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Photosensitivity reaction
Clinical narrative: Head pressure; Light sensitivity; Extreme anxiety; Fatigue; Nausea; Vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 17:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), dysautonomia, lyme disease, antiphospholipid syndrome and  sulfonamide allergy (sulfa abx). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 20:00, the patient experienced head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams were not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, SARS-CoV-2 test
Clinical narrative: Diarrhea; This is a spontaneous report from a contactable consumer. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN), propranolol (MANUFACTURER UNKNOWN) and multi vit (MANUFACTURER UNKNOWN) all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 09Mar2021 at 14:00 the patient experienced diarrhea. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 09Mar2021, the patient underwent lab test and procedures which included nasal swab and the result was unknown. The clinical outcome of the event diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site (upper left arm); This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 at 10:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included peripheral neuropathy and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 04Mar2021, the patient experienced soreness at injection site (upper left arm). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at injection site (upper left arm) was recovered on unknown date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 25Feb2021 at 09:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included alendronate sodium (ALENDRONATE) and colecalciferol/calcium citrate (CALCIUM CITRATE + D3) on an unknown date for an unknown indication and unknown if ongoing. On 27Feb2021, the patient experienced sore left arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left arm was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: After second vaccine, I had a severe migraine headache the day after. Been three weeks since second dose, and have had a migraine every day to varying degrees since then. I've gotten migraines before, but never to this extent.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Feb2021 at 09:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications within two weeks of vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Jan2021 at 12:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 16Feb2021 at 08:00, the patient experienced had a severe migraine headache the day after. It had been three weeks since second dose and had a migraine every day to varying degrees since then. The patient got migraines before, but never to this extent. Therapeutic measures were taken as a result of migraine headache and included treatment with aspirin (MANUFACTURER UNKNOWN) and other type of pain medications from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine headache was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Fatigue, Pain in extremity
Clinical narrative: Sore arm; Fatigue; Little disoriented; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 00:00 as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN); from an unknown date for an unknown indication and was unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Mar2021 at 15:00, the patient experienced sore arm, facial muscles, fatigue and a little disoriented. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events sore arm, facial muscles, fatigue and little disoriented was recovered on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: No desire to eat; The next day "I" did not feel the pressure "I" have felt due to COPD. The heavy tight pressure on "my" chest from COPD was gone.; Lack of energy; "I" feel spacey, sometimes dizzy.; "I" feel spacey, sometimes dizzy.; "I" will say "I" have been so very very tired since shot and now going on day 3; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 04:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, sulfa drug allergy, chronic obstructive pulmonary disease (COPD), asthma and heavy tight chest pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), tiotropium bromide monohydrate (SPIRIVA), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin(unspecified), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took minocycline hydrochloride (MINOCIN), cefoxitin (MANUFACTURER UNKNOWN) cefaclor (CECLOR) from an unknown date and experienced allergy. On 06Mar2021, since the shot, the patient had been so very very tired and was going on day 3 at the time of report. The patient had reported that first there was a good event on 07Mar2021 at 08:00, the next day after vaccination, the patient did not feel the pressure she had felt due to chronic obstructive pulmonary disease (COPD). The heavy tight pressure on her chest from COPD was gone. It was reported that the patient had COPD for a long time and had forgotten how it felt not to have had the pressure on her chest. She reported that it was amazing and it was a miracle. On 07Mar2021, the patient felt spacey, sometimes dizzy, no desire to eat and lack of energy. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event did not feel the pressure that was felt due to COPD was unknown, while the clinical outcome of very very tired, felt spacey, sometimes dizzy, no desire to eat and lack of energy were not recovered at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: No desire to eat; The next day "I" did not feel the pressure "I" have felt due to COPD. The heavy tight pressure on "my" chest from COPD was gone.; Lack of energy; "I" feel spacey, sometimes dizzy.; "I" feel spacey, sometimes dizzy.; "I" will say "I" have been so very very tired since shot and now going on day 3; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 04:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, sulfa drug allergy, chronic obstructive pulmonary disease (COPD), asthma and heavy tight chest pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), tiotropium bromide monohydrate (SPIRIVA), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin(unspecified), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took minocycline hydrochloride (MINOCIN), cefoxitin (MANUFACTURER UNKNOWN) cefaclor (CECLOR) from an unknown date and experienced allergy. On 06Mar2021, since the shot, the patient had been so very very tired and was going on day 3 at the time of report. The patient had reported that first there was a good event on 07Mar2021 at 08:00, the next day after vaccination, the patient did not feel the pressure she had felt due to chronic obstructive pulmonary disease (COPD). The heavy tight pressure on her chest from COPD was gone. It was reported that the patient had COPD for a long time and had forgotten how it felt not to have had the pressure on her chest. She reported that it was amazing and it was a miracle. On 07Mar2021, the patient felt spacey, sometimes dizzy, no desire to eat and lack of energy. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event did not feel the pressure that was felt due to COPD was unknown, while the clinical outcome of very very tired, felt spacey, sometimes dizzy, no desire to eat and lack of energy were not recovered at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Feeling hot, Heart rate, Hyperhidrosis, Hypertension
Clinical narrative: felt hot; sweaty; queasy; 140/106-b/p; This is a spontaneous report from a contactable other hcp.   A 51-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular on 26Feb2021 15:00 (Age at vaccination 51 years old) (Batch/Lot Number: EN6203) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Penicillin. The patient's concomitant medications were not reported. on 26Feb2021 15:00 the patient experienced felt hot, sweaty, queasy, 140/106-b/p. The patient underwent lab tests and procedures which included blood pressure measurement: 140/106   on 26Feb2021, heart rate: 77 on 26Feb2021, oxygen saturation: 97 % on 26Feb2021. Outcome of the events was recovered on unspecified date of 2021.  No follow up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation
Clinical narrative: felt hot; sweaty; queasy; 140/106-b/p; This is a spontaneous report from a contactable other hcp.   A 51-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular on 26Feb2021 15:00 (Age at vaccination 51 years old) (Batch/Lot Number: EN6203) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Penicillin. The patient's concomitant medications were not reported. on 26Feb2021 15:00 the patient experienced felt hot, sweaty, queasy, 140/106-b/p. The patient underwent lab tests and procedures which included blood pressure measurement: 140/106   on 26Feb2021, heart rate: 77 on 26Feb2021, oxygen saturation: 97 % on 26Feb2021. Outcome of the events was recovered on unspecified date of 2021.  No follow up attempts are possible. No further information is expected.